Piper Sandler analyst Patrick Moley raised the firm’s price target on CME Group (CME) to $250 from $240 and keeps an Overweight rating on the shares. The firm notes CME has seen the largest growth in consensus EPS estimates among U.S. exchanges this year, but no multiple expansion.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio